!
"
#$
%
% &
! "
" #$ % &$ ' ()
* + '
,- $
,-.
/#(0 , !
, 1 2 $ !
% '
3 " ' 4 56# ( 789 4
-AlCl3
: ' ;$ : (3 4 <# () 4$)- = >
< $ 8 '8 ? + 1 = '
( ? @#(!
= 4 ( A8
B B $
C 3 %
4 :D > ,' 4$
#> $ 3 " ' $# >! # $ #> E ( >
F < G
( H <'
< G : :<'
E A$ * ) B # $ ( H
A$I
3 J #( 3> KL$#3 4 MN!
P 0.05
H$:M $D:3 A$ 3 A$O$)@3P
-4 $ #@P ,/@ # E # 1# B *H' ?
' % &
,/:@ Q : 4 > > 1 4$ >
.L$ + $( ?O " &$%#3"
40 ? 3 . R$39 '#
$)@3P B ' M H ' # - - $ /@ %
> 3> * 3
F < G <'
>! ? 3 E $ H ?1 )# MN! 4$ ' ? ' ? ( H
3> ) $ /@
#
:> 3> E D 5'! 43$' ' ' ;$ ? (3 4 <# N%
< G
? (3 4 <# N%/# ( H <'
$# D + 1
I
Histophysiological study of aluminum chloride effect on male rats
K. H. Al-Mallah* , N. A. Hassan**, E. M. Abdul-Rassoul**
*Department of Pathology and Poultry Diseases, ** Department of Physiology, Biochemistry and Pharmacology, College of Veterinary Medicine, University of Mosul, Mosul, Iraq
Abstract
This study was designed to detect the effects of aluminum chloride AlCl3 on some pathophysiological features of adult male rats. Eighteen rats were divided to 3 groups of 6 animals each. These included untreated control and 2 treated groups received AlCl3 at the doses 40 and 80 mg/kg of body weight, orally and daily for 30 days. The following parameters were recorded: Body weight (weekly), central nervous system activity tests (weekly), hematological examinations at 15 and 30 days of experimentally and gross and histopathology for brain, liver, kidneys and heart at the day (30). The results showed a significant decrease in body weight mean of 3rd group (80 mg/kg) at 4th week, a significant decrease in the activity associated with time progress in experiment by recording (moving onset, square crossed and rearing in 3 minutes, negative geotaxis) tests, there were no significant differences between groups at pack cell volume and hemoglobin concentration with a significant decrease in total leukocyte count at 2nd group (40 mg/kg). Differential leukocyte count revealed significant increase in lymphocyte at day 30. Histopathological changes were neuronal vaculation and proliferation of microgelial cells in brain, vacular degeneration and lymphocytic infiltrations in hepatic parenchyma with mild portal fibrosis in liver, at kidneys there were cloudy swelling, coagulative necrosis to the renal tubular epithelium, more severely noticed at 3rd group, no pathological changes were noticed at myocardium and coronary arteries at both treated groups.
(
3 " '
AlCl3
L$D: 3 " S/ ! %!
S/: ! +:3$ L$: =: > A$ ( A 56# $M 6
)3-4$)( 4$# ' 4 #3' J @" 3 "
:3> 3 "
) . > $M'/M#(!
I : L$ ' T# :-$@ + (
4 8 4$3 #' U , 1#( '
: $M
Halid atoms
:1
4$: $ ' # >$3- ? B( .$ 3 = > T @#(P $D
8VU N $% 9 $ ;$ -" "
I
7 4$ #( 3 "$ $ #9" # E #)
T:# 56# ,@ :# + ( ( %$3 8V" L ?
(
E : > J @! 4$ ' B N%/
I : # !
,'D ?#6# L 3 " 4$ ' = 4$3 % $(3"
: " = $O"$ " + D 7$ W # ?($(!
4$ ' 789 = > $%
F I
: #$1 > %# # 1
)-3
LD50
3 " 4$ ' 5'
L 5
: 3 " ' ? S ## W % $ %- N3 ,
< G
8 ? ( H <'
X I
,'D +( # D#3 3 " 6 ( 4$( 4 $D!
;$ = ' -@ ' $N ? ?($(!
C I '8
5%$ 6
:M " $ D ? A$O ! +( # 3 "
V$ D
I
5%$ $ '
J #(: E $ H !
# B A$ # ( (3! ,- ? 3 "
$9H ' - ('3# "
I
5%$ $D!
3 " ' &$ >! ! =
* Y +3 U E $: H =
,- ? ' L$ @ $D3
9 : Z3H# , $ E $ H
I
: ' 56:# : : $% $3#( 4 M#(! 1 R 8
H: ' # T:L$ >P 3> < $ 8 '8 = > 3 "
)-: ?: 4 : <# $# ,/@ MD E ) #@
;$ (3 3$ O
'
= ' + 1
() 4$)-I
" ) *+ ,
: :< $ &$O 8 '8 @#(P #
F
S ## H 6 MD!
X
$9H M # # V
# 4 ! W % * + ' ? 4$3 % 4
:N ' #(/ [$) ! ? 8 4
:($ Q
A$ E&$OP >$(
E %
X \ L
>$( = > & 8< &$ $M
I
3 " ' @#(!
AlCl3
' :D ,: HM
(BDH chemicals, ltd., poole) British Drug House
&$ $ T# 8P 4 # ! . %( ,'D 6D3 H '3!
1
B # ,L$( = > , -%
I
@#(! = A$ L D> $M (1# # A8
B B $
C
. > 3 " ' 4> > ,' 4$3 %
?#"$' B # + 3! @#(6 )
]
= " > ]
$ V E ( >
I
3$5 >
]
3 " ' 4 #(!
> F :< G
A$ ( H <'
I
5 $5 >
]
> 3 " ' 4 #(!
:<
G
$ ( H <'
^ I
E # 4 #(!
H ! _$: $:M /@ # A$
(
*H:' ? -: H$:M $D3 4 $ #@! & !
%) 4 ! A$ > (!
$ " 3>
4$-X :
# ` 3>
4$3 % $ %O# 4 # #
B @
?3$: ?:O [%) $M > * !
? (3 I +%( #
D + $3! @#(6
Hematocrit tubes
=: > $% ) N3 + $3! ? 4
$O 5@#
EDTA
_$: : 4$- %) 43 O#
' M H ' #
HB
:- - $ /@ %
PCV
4$ ' ? '
Total WBC Count
:
: : 4$ ' ?1 )#
Differential leukocyte
count
I
@#(6 < $ ?> (0 ( H 8@ #
8 H
E % )'
H$:M $D:3 4 $ #@! 43 O# $ 3
*H' ?
-X F ] !I
,@ ?' % $D3
S #)
Open field activity
4 D ] A0 ! a & : $: #@!
' % F I A$ 3$5
8 $9H$# ?# 4$ > _$
? .L$ F I A$5 $5
?: Q 4 >
.L$:
F I
+ $(: ?:O " &$:%#3" $: #@! =: $O"$
Negative geotaxic test
X I
;$ : ,' (3" 4$3 > B #
: ' =: '
4:N)% E D$ ?3$ ?O [%) & ! + 1
, $ # b $ ) , % ?
c
& : P $9 #
4 # ( (
B :D , : H ? 5" , %' @#(d
S D H$M B 1# D + ? +- 5 $
(:' #$ M 3 # < - @#(d eL D 4<
-H "
H&E
C I
M $: eL D [% $9 #
?L O
:3 : $' @#(6 $9 -#
Sony
3$ $ 6D3 I
, $ KL$#3 > # #
\ ,: %# # ?($ 1 f$ @
$: # , %# $ #@P @#(6 KL$#3
One way analysis
of variance (ANOVA
B $: 4$ ) 4%O
3 J #( 3> $'3 $ #@P @#(6
P 0.05 17
-+
$ # .
. : *! : > (" ( H ! KL$#3 MN#
: # B $(! $' 3> W/5 # B $ 3
, * 3 $)@3P N% W % B (" >
5 $5 > H !
3 " '
< G
H <'
(
3$5 > >
3 " '
F < G <'
( H
$)@3! N% 1 E % > O $ !
:3> W: $5 :(" > B (" H ! , ?
, 5 $5 >
I
, ]
# B $(! ,/@ ) #@ B $ > (" ( H ! ? 4 <#
I
B $(0 >
# &
, " ("
?3$5 ("
W $5 ("
B ("
E (
X` \ C`
a
` \ `X
a
` \ C`
A
`C \ C`C
a
` \ `
ab
3 " '
F < G <' `
\ X`
a
`C \ X`
a
` \ X`F
A
` \ C`
a
FF` \ X`F
a
3 " '
< G <' `
\ X`
a
` \ `
a
` \ `
A
` \ C`
a
\ `
b
4$3 % >
g C
> ,'
I
, $ $M3> 1
V \ ?($ 1 6 @ I
$ #%! J #( 3> 3 A$ ?3 # A$ > A$ 1 ! ) #@ Q %"
P 0.05
I
/. #%) . 0 ,
!
S #) 4 $ #@!
A0 !
' % & $ #@!
& : $: #@! 40 : ? 3 . N%/
: =: " W/5 B $(U ) #@ B $ ' %
#
* :3 . )# B (" 3> N% $ 3
E ( > > 3$5 >
# $ 3
. , (
E % > O ) #@ B $(" 40 3
I
, I
A$ 3$5 > $ #@!
? > 1 4$
.L$
4$: > ? * 3 $)@3P KL$#3 4 MN!
? > 1
:> # $: #> ,' .L$
MN $ 3 E ( >
: $' * :3 . $ M3
# B $(!
, )@3! 1 E % > O $ !
? : :)@3! R 8:' , " (" > ?3$5 ("
: 3$5 :> 3> ?3$5 > B W $5 > ("
B: : # B $(! ? $ > W $5 (" , )@3!
" > (" . )#
3> B (" > A$ 3 ?3$5 ,
5 $5 >
I , I
A$5 $5 @!
? Q 4 > $ #
.L$ ]
: * :3 . : > $ #@" KL$#3 4 ( 1
, " (" 3> ) #@ B $ 40
N% : $: 3
> # $ #> * 3 $)@3P
E ( >
:(" 3> 3$5 > 5 $5 > , $)@3! B
#> : * 3 $)@3! N% R 8' # ?3$5
3> $ M3 * 3 . E ( > > # $
B W $5 > ("
N% : E :% > O
(" ? * 3 $)@3!
? : > B W $5 >
3> N% $ 3 3$5 > 3> ?3$5 , " > ("
? $: > , " (" , A$ 3 A$ )# 5 $5 >
$5 (" , A$O$)@3! # B $(!
:(" > W
# ?3$5
, ]
# B $(! ,/@ ) #@ B $ S #) 4 $ #@ KL$#3 ? 4 <# eO
I
B $("
> $ #@0
, " ("
?3$5 ("
W $5 ("
B ("
' % & `
\ `
bc
`C \ `
C
`X \ `
c
` \ `
bc
>
? > 1 4$
.L$ F `
\ `X
a
F ` \ `
A
F `X \ `
a
FX` \ `C
a E (
? Q 4 >
.L$ `
\ `
ab
F` \ `
A
`X \ `
ab
` \ `
b
' % & `X
\ `F
abc
` \ `X
Abc
`X \ `
abc
` \ `F
a
> 1 4$ >
? .L$ \
`
b
`X \ `C
cd
X`C \ `
f
`X \ ` X
ef
:::: '
3 " F
< G <'
? Q 4 >
.L$ `
\ `
b
`X \ `
b
` \ `
d
`C \ `
d
' % & `
\ `
bc
`X \ `
abc
`X \ `
abc
` \ `
ab
? > 1 4$ >
.L$ `
\ `
b
`X \ `
bc
C \ `
f
` \ `X
de
:::: '
3 " < G <'
? Q 4 >
.L$ `
\ `
b
F` \ `
c
\ `
d
`X \ `
cd
4$3 % >
g C
> ,'
I
, $ $M3> 1
3$5 B
G .L$ )
G .L$ ? # = > \
?($ 1 6 @ I
O^ $ > A$ 1 ! ) #@ Q %"
$ #%! J #( 3> 3 A$ ?3 # % $ #@"
P 0.05
I
+ + $( ?O " &$%#3" $ #@! ]
5 $5 > * 3 . )# $ #@" KL$#3 4 MN!
N%/ , " (" 3> 3$5 E ( ?#> >
B $ * 3 .
(" 3> #
$: 3 ?3$:5
:> E (: > > 3$5 > 4 )#
> # $ #> 4 )# W $5 (" 3> 5 $5
# B (" 3> A$ 3 E ( >
$ !
W: $5 > :(" ? . )# 1 E % > O
, " (" > B
?3$:5 > W $5 (" . )#
W: $5 (" , )@3! 3$5 > 3> A$ 3
" > (" ? > A$ 3
:> :3> B ,
5 $5 I , I
1 % 2
3 . > 4$- %) KL$#3 4 MN!
' M H ' # 40 ?
- - $ /@ %
,' $' # B $
X
: #
I
A$: 3 A$:O$)@3! : : 4$ ' ? ' MN!
3$5 >
: 3 " '
F :< G
H :<'
(
3> 5 $5 E ( ?#> >
X
#
:O A 3 A$ 4$- %) 789 MN#
: : E % >
X
B $: : $'
, ]
# B $(! ,/@ ) #@ B $ + $( ?O " &$%#3" $ #@! KL$#3 ? 4 <# eO
I
B $(0 >
" ("
,
?3$5 ("
W $5 ("
B ("
E (
F`C \ `
c
F` \ `F
c
C` \ `
c
X` \ `F
c
3 " '
F < G <' C`
\ `
c
` \ `
bc
` \ `
a
\ `F
ab
3 " '
< G <' `X
\ `X
ab
` \ `
bc
F`X \ `C
c
` \ `X
ab
> 4$3 % g
C
> ,'
I
, $ $M3> 1
3$5 \ ?($ 1 6 @ I
$ #%! J #( 3> 3 A$ ?3 # A$ > A$ 1 ! ) #@ Q %"
P 0.05
I
, F ]
3> ) #@ B $ 4 $ #@" KL$#3 ? 4 <# eO
X #
I
* [%)
' M H ' #
- - $ /@ %
4$ ' ? ' >
X X
X
E (
X`F \ `X
a
F` \ `X
a
F ` \ `
a
F `C \ `
a
` \ `
a
` \ `
a
3 " '
F < G <' X` \ `X
a
F` \ `
a
F ` \ `
a
F `C \ `
a
` \ `F
b
`C \ `
b
3 " '
< G <' F` \ `F
a
F` \ `
a
F `C \ `
a
F ` \ `
a
` \ `
a
` \ `
a
4$3 % >
g C
> ,'
I
, $ $M3> 1
V G
(3 # ?(
c ' G ( ? # = > \
@ ?($ 1 6 I
$ #%! J #( 3> 3 A$ ?3 # A$ > A$ 1 ! ) #@ Q %"
P 0.05
I
:3> 4$ ' ?1 )# KL$#3 4 MN! 1
X
40 : ? 3 . > #
? W/5 # B $ 3> 4$O % 40 ,'
( %
, : ?: A$: 3 A$O$)@3! 5 $5 > 4
A$: 3 A$O$)@3P R 8' E ( > , > 4 1
E ( ?#> ,' > E 3 E % $ /@ , ?
3$5 I
:> > A$ 3 5 $5 > 4 )# $ 3
) $ /@ >! , ? 3$5
3> :
40 >! , ? * 3 $)@3! N% #
,: $1 3$5 E ( ?#> > 5 $5 > 3>
E (: > > ) $ /@ , ? A$ 3 $M )#
4$O: % , ? A$ 3 5 $5 > 4 )# R 8'
$ 3 3$5 > >
# $ #> /' 4 (
:> > E 3 E % $ /@ , ? A$ 3 A$O$)@3!
4 : 1 , ? 3 . N%/ E (
$' # B $ 3>
:)@3! E % > O
? E 3 E % 4$O % ,
> X
3>
>
40 , )@3! 5 $5 > 3> 3$5
? >
X
? 4 1 , B)# !
? T > $' $ > X
# I , X I
) 3 4 2
#> : :3> EH 3$ > O 4 <# N%/#
(: > > # $
&$O:>" B: :3> E
? Q ) + %D ;$ ? ( $1#%! J ( - %)
:5 $5 > 3> 4$3 % '
: '
< 3 "
G <' I
( H
, X ]
3> ) #@ B $ 4$ ' L +(3 40 ? 4 <# eO
X #
I
> 40
4$O % 4 1
4$ ) E 3 E %
X `C
\ `
a
` \ `
a
` \ `F
a
`C \ `X
ab
`X \ `X
a E (
` \ `
a
` \ `
ab
` \ `
a
` \ `C
b
` \ `
a
X X`
\ `
a
F` \ `
a
` \ `
ab
C ` \ `
b
`C \ `
a <'G< F 3 " '
\ `X
a
` \ `F
b
` \ `
a
` \ `
ab
`C \ `
b
X `
\ `
a
` \ `C
a
` \ `
b
X` \ `
a
` \ `
b <'G < 3 " '
` \ `
b
X` \ `F
a
` \ `
a
` \ `F
a
`X \ `
b
4$3 % >
g C
> ,'
I
, $ $M3> 1
c \ ?($ 1 6 @ I
$ #%! J #( 3> 3 A$ ?3 # _)3 O B $ > O A$ > ) #@ Q %"
P 0.05
I
O 4 <# ? (3 ?O [%) MN! 1
D ( # = ) )
> A$($ $ B $ 3> E
E (
I
5 $5 > 3> E D 5'! 43$'
N% : W %
4$3 % N 3> > U $1#%! ;$ ?
$:' - $ /@ ? )# B # $ #> O
5 $5 > 3> E D 5'!
I E -I
5$'# B 4$ 1
# $: #> : ? 4$3 % 3> E
<-I
E -I
E -]
5 $5 > 8 ;$ ? ? (3 B 1
3 " '
< G
( H <'
,:% eO
V$ - $ /@ ? )# ) #@
A
I : '# E
X100
<
-H&E
I
, % ' $ /@ * ) _'3# ' ? N%
:N :3> : H' E " $1#%! B H' E "
+$O:@ +:( # :5 $5 : 3$5 #> : 4$3 %
: @5# $1#%! MN * ' # ? ( M
) ) 4$%$D# ! ' $ 4$%$ D
4$ U
3> ) $ /@ )
:5 $5 > 4$3 %
I
-X
I
E -]
:5 $5 :> : 8 ;$ ? ? (3 B 1
3 " ' <
G
( H <'
$: /@ ? )# eO
-A
E <- 4$ 1 5$'#
B
> " $1#%
C
I '# E
X145
<
-H&E
E -]
:5 $5 :> : 8 ' ? ? (3 B 1
3 " ' <
G
( H <'
: $1#%! eO
*H'
A
' $ /@ * ) _'3#
B
+$O@ +( #
( M
C
I E '#
450 X
<
-H&E
I
E -F ]
:5 $5 > 8 ' ? ? (3 B 1
3 " '
< G
( H <'
$:1#% e:O
A
$ D Q #
B
S$D:# ! B $: /@
4$ ) $M V! $M# !
C
I ( M +$O@ +( #
D
I '# E X
X
<
-H&E
I
E D1 ? D > " $1#%! N% # ' ?
+: 3 $: /@ ? < _'3# ,% B * ' +
:> 3> E D 5'! # $ #> 3> * '
)# H3! B 5 $5
I
* Y ? # @3 N%
$M# ! 4$%$D# ! B
: 3 : % 3> 4$ ) $M V!
5 $5 >
I -C N:%/# : + 1 ? $ !
E ( > > EH (3 4 <#
4$%$D:# ! J (
4$3 % %! 3> 1 4/O ( )
>
3$5 I E
-X ] 1#%! eO # . $( ,'D E ' E -$
A
$ D Q #
B
$: /@ S$D# !
)
C
' $ /@ * ) _'3#
D
I : '# E
X 450
<
H&E
I
E -C ]
:5 $5 :> : 8 ' ? B 1
> " $1#%! eO
A
? < # ! _'3#
' 4$ 3 $ /@
B
$M) $ # . O# B
C
H3! B
) )@
D
I '# E
X 370
<
-H&E
I
E -]
:5 $5 :> : 8 ' ? B 1
? < _'3# eO
A
? # @3
B
+ 3 $ /@
* ' I '# E
X 450
<
-H&E
-E ]
:5 $5 :> : 8 ' ? B 1
#: ? 4$ ) $M V! $M# " $ /@ S$D# ! eO
* '
A
? # @3
B
? < _'3#
C
4$ 3
> " $1#%! '
D
I : '# E
X 165
<
-H&E
I
E -]
B 1
: 3$5 :> : 8 + 1 ?
1 D $1#%! eO
A
$: /@ (: S$D# !
1 4/O )
B
I '# E
X 450
<
-H&E
I
5
, * 3 $)@3P ( KL$#3 N% 1
5 $5 > H !
" '
3 <
G
H <'
(
3$5 > >
F < G
( H <'
3>
H ! , : ? $)@3! R 8' # B ("
T $D: 89 5 $5 > O W $5 > B ("
5%$ 7 '8 $
3 0 ' +3 " B # !
J !
( H ? * 3 $)@3! =
& 8:< , $:3#
A$:($ : $ > 3> ?3 # $3 H # &$
E ( $
5%$ 7 $ T $D R 8'
:
,:< +/' 3> ( H ! = > 3 " 56#
Beagle
dogs
L)
Mice
? # = > I
R 8 JH 56# =
(:3" ? T ' # L$ @ " = > 3 " '
* ('6# M T5 %! > A/O ) #@
5%$: 1
!
# ' ) O = > A$ ( 5Y 3 " ' &$ >!
: " : $3 :3 " ?# @ $ E $ H ,/@ $M #
ALT
$3 4 # $ (" "
AST
* 8 W :%! R 8:'
N
Osteoporosis
E $: H ,/@ = ' ' @3 !
* 1 H$#)() ?# @ $
ALP
?O: $% H$#)(:)
ACP
E : @ : $ ,: 1# :> A/O
Glutathion-S-transferase GSt
8: %# E $ H E ('U E $O
::@ :: T::3> QD::' ::# E ::%
, :: $ E $:: H ,/
Thiobarbituric acid -reactive substance TBARS
=: E O $ * Y Q ( R 8 ,' ! W % $ H/ ?
T:# '! $ 89 $ B $ 3> H +$(#'! $)@3!
4 :MN! ?# $% $3#( (3 O 4$- %)
' ,' ? O 4 56#
= ' I
*H' ? - H$M $D3 4 $ #@" KL$#3 4 MN!
E ( > $ B $ 40 * 3 $)@3!
4 : :> > 1 4$ > * $ #@! ,' ?
? Q
40 : 78:M * 3 $)@3! R 8' .L$
B $(! 1# B $ B $ O
: #
:% ?:
:> : $ B $: 40 3 E $ H N%
. :)# R 8:' + $( ?O " &$%#30 $ #@! 3> E (
?: :' % & : $ #@! 3> E ( > 3$5 >
# B ("
I
= S O D# KL$#3 789 P
M $D3 )@ 56#
,: *H' ? - H$
( ? # #( #> $ 3 " '
8:9
5%$ 7 '8 $ T $D
: 3 " ' &$ >P !
> 8 A$
C < G
( H <'
E
#: =: > $M# : $:M# ' 8 A$: 3 ,H:#@ MD!
Memmory and Learning
5%$:: ::
!
> 3 " ' &$ >P
C
8 : E %
+ :M , '( E # A$ 3 , #
Escape latency
W% $(
Searching distance
-:1 = > , $
?V$
Brain dysfunction
5%$ '! % ?
!
' R/M#(!
E : @ $D:3 $)@3! = * Y 3 0
H #(! ' , $# ("
AChE
, 3 4$ #(
Biogenic
amine neurotransmetters
$::3 ! 3 $ :: $'
: $ 8 : 3> ;$ . $3 $' ? 3 # (
> 3 " '
F < G
E : (: H :<'
> (! I
: N% : W: % ;$ ? (3 ?O [%) KL$#3
5$'# - $ /@ ? )# V$ > 0 $1#%P
/' 3 " ' $ 8 3> E <- 4$ 1
#> 5%$ 7 '8 $ B .)# 89 :
8: Z @ ? >$@3 H! ? )# $' ('3# 4 <#
> 3 0 ' $ 8 ? ;$
X < G
E <'
5%$: N:%0 $ 3 A$ F
$:O!
: A$ @ 8 ;$ - $ /@ > H 3 "
MN + (#
K : $ /@ 4 ,%
Apoptosis
I
> = > 3 " E = # (3 4 <# 789 P
4 #( $ 7 $%#! V$ H %
Citrate
?:
: > ?: &$ " [# 3 " N e 3 0 %
)(3 # $ T $ # ! + ( H % 789
Transferrin
R 8
'# A$ ( ? - H$M = > 3 " 4 56# MN# 0
)(3 # 8$)3#(! 3 " , @ B ' #
X I 3>
A/ 5'! ' 3 #' " T-L$-@ + ( 3 0 , @
,>$)# T' #D! @ 4$3 ' $ $%#/
Redox
h$#3"
E % 8
C
? - O N W % ? $# $
,$ 3 " $%#!
DNA
,
RNA
-: $ /@
,H:#@ ?V$ K (3 ? 3 " ' # ! > A/O 89
:-$@ ;$ ? R3H _$%3 % ,' 4$ #(
, ?
Hippocampus
+ ( ;$ ) O - = A$ Y
3 789 [13
% -$
I
?: 3 . *! 4$- %) MN#
: :- - $ /@ % ' M H ' # 40
3 " 5# , % 4$( V $ # B $
% 4$ ' B 3-#
Erythropoisis
: 1 W %!
:3 :
Hyperchromatic ferripenic microcytic
anemia
I
$MN" $' V # E # '# $
: V $: 4$- %) ,/@ A$ 3 56# 89
3> ' ? ( M +$O@ +( # 40$% E > MN
$: /@ (:'# W % A DY # *8 $ B $
" ' $ 3 %
: 4$ ' ? ' 40 $)@3
> + ( %O ( 0 3$5 > 3>
: =: >! :> #(# ?# 5 $5 > 3> $9 56#
3 0 '
I
. :)# : : 4$ ' ?1 )# MN!
> 3> ) $ /@ , ? * 3
? 5 $5
4: )# R 8' 3$5 > > # D> _ $@
40 : +$(% = > E ( > > 5 $5 >
R 8' 3$5 E ( ?#> 40 > 4O)@3! ?#
4$O % , ? 3$5 > 5 $5 > 4 )#
I 789 P
>! ? (3 E $ H
$ > 3> ) $ /@
W :% + (: :'# 3 " ' = >" H ' # $
* ('6# M H ? (3 O
I
O 4 <# ? (3 ?O [%) MN! 1
: ' # $ #> 3> = ' ' ,' ?
) _'3# $ 4 5 # 3 0
( Q # ?) S$D# " *
' ? $ 4$%$
?: # :@3 ? < _'3#
' ? 4$ 3 $ /@ * Y 7 :'8 $ T $D# KL$#3 789
5%$
B: +:3 U 3 0 ' &$ >! !
L$: @ $D:3 A$ 3
ALT AST ALP ACP
?:
$ H/ $ T $D# R 8' * ' J8" 3> E $> B)# # ?#
5%$ T# '8
8 : 3 " ' &$ >! !
R $% 4$ #( H
Uric acid
? 3 #$ '
* ' -1 $ A$ ( # # $ A$ $V ?# $ H/
5%$ ' &$ >! 6
E 8 3 "
F
> A$
< G (:3 4 : <# W :% :<'
= ' ' ,' ) O
I
5%$: :'!
6:
W :% ' ) O = > ? ( 56# T 3 " '
E D:1 :1 3 ? -$@ * ' K (3 ? A$ ('6# A M
8 3> '
I
' ? O 4$ " MN H' # P
$: /@ ? [$@ ,'D 3 " +( # = JH = '
# : ) E ' 4$ ' = > $ML #%! + ( &$O>" 789
Ferritin
78:M $:%#U D: 3 " , + (
78:9 ?: A$ # # ) 4$ #( , 1 T36 4$ '
? / % J #( , $1 ? B (3"
Non heme
iron
: $ % = > E 1 $ /@ 789 1)# W % $ /@ 789 ?
:: % :: Q3-:: 8::9 :: $M(::)3
Protective
sequestration of iron
W :%# ? $:# $ # ) $M3 1)
O:> @ 4$ ' = > $O $9 56# % 4$3 !
$M#$
3
I 5%$ T# '! $ 89
, $ ? E $ H
: ' $ 8 3> = ' ' ? 9 Z3H#
+ 5'! 3 "
`X =
V B $ 3> 7 #( Q$ O!
, 4$ #( , 1 T3! $
DNA
,
RNA
#
' ' (3! ?
: $ B $ J ;$
I :
D + 1 ,O ? (3 ?O [%) KL$#3 MN#
:O 4 : <# # $ #> 3> $#
5%$: 7 '! $ V $ E ( > > EH
$# D M " ? 3 " +( # 3$' P
I
(
+: : ' E $: > = 1# 'D $ 5%$ 1#
4: E ! () " > ?> ($L *
W% 789 & ! ? $3 M > = > ' ? 4$3 %
%
1. WHO. Guidelines for drinking water quality,2nd ed.vol 2 Health criteria and other supporting information.Genova, World Health Organization. 1996.
Available from
http://www.who.int/water_sanitation_health/dwq/wsh0304_53/en/inde x2.html
2. Galatsis P.Handbook of reagents for organic synthesis : Acidic and basic Reagents.Reich,H.J.;Rigby,J.H, Wiley New York. 1999: 12-15. 3. Salnina P, Falkeborn Y, Frech W, Cedergren A. Aluminium
concentration in the brain and bone of ratsfed citric acid, Aluminium citrate or aluminium hydroxide. Fed Chem Toxic.1984 ; 22 :391-397. 4. Jones XC, Bennett BG. Exposure of man environmental aluminium –
an exposure commitment assessment.Sci Total Environ. 1986 ; 52 : 65-82.
5. WHO. Aluminium. Geneva. World Health Organization. International programme on chemical safety. Enviromental health criteria.1997
;194.Available from :
http://www.inchem.org/documents/ehc/ehc/ehc194.htm
6. ATSDR (Agency for Toxic Substances and Disease Registry). Toxicological profile for aluminium.U.S.Department of Health and human survices. public health Survices.1990.Available from : http://www.intox.org/databank/documents/chemical/alumchl/cie782.ht
m
7. Minami T, Ichii M, Tohno Y, Tohno S. Age dependant aluminium accumulation in the human aorta and cerebral artery.Biol Trace Res.1996 ; 55:199-205.
8. Bush VJ, Moyer TP, Batts KP, Parisi JE. Essential and toxic element concentrations in fish and formula-fixed human autopsy tissues. Clin Chem.1995 ; 41 :284-294.
9. Sallam SMA, Nasser MEA, Yousef MSH, El-Morsy AM, Mahmoud SAS, Yousef MI. Influence of aluminium chloride and ascorbic acid on performance, digestability, cecal microbial activity and biochemical parameters of rabbits. Research Journal of Agriculture and Biological Sciencees. 2005 ; 1 :10-16.
10. Bennett RW, Persaud TVN, Moore KL. Teratological studies with aluminium in the rat. Teratology. 1974 ; 9 : 8-14.
11. Guidelines for the use of cervical dislocation for rodent euthanasia [ Internet]. Institutional animal care and use committee (IACUC); C 2008 [Cited 2008 Jan 8]. Available from: utexas.edu/research/…/forms/guidelines_xii_cervical_dislocation.pdf 12. Timm K. Orbital venous anatomy of the rat. Lab Animal Sci. 1979 ; 2
: 663-670.
13. Coles E H. Veterinary clinical pathology. 3rd ed. WB.Saunders company.Philadelphia.USA. 1980.
14. Moser VC, Anthony DC, Sette WF, Macphail RC. Comparsion of subchronic neurotoxicity of 2-hydroxyethyl acrylate and acrylamide in rats.Fun Apl Toxicl. 1992 ; 18 :343-352.
15. Mohammad FK, Omer VEV. Behavioral and developmental effects in rats following invitro exposure to 2,4-D/2,4,5-T Mixture. Neurobehave Toxicol Teratol. 1986 ; 8 :551-558.
16. Luna LG. Manual of histologic staining methods of the armes forces institute of pathology.3rd ed. McGraw-Hill book company, New york. 1968.
17. Steel ROD, Torrie JII. Principles and produces of statistics. New York : Macgraw _till Book Company. Inc. 76. 1960.
18. Pettersen JC, Hackett DS, Zwicker GM, Sprague GL. Twenty-six weeks toxicity study with KASAL (basic sodium aluminium phosphate) in beagle dogs. Environ Geochem Health. 1990 ; 12 : 121-123.
19. Albina ML, Bells M, Sanchez DJ, Domingo JL. Evaluation of the protective activity of deferiprone, an aluminium chelator on aluminium induced developmental toxicity in mice. Teratology. 2000 ; 62 : 86-92. 20. Shi-Lei S, Guang-Yu MA, Bachelor LH, Dong HM, Xu XH. Effect of
Naloxone on aluminium –induced learning and memory impairment in rats. Neurol India. 2005 ; 53 : 79-82.
21. Gong QH, Wu Q, Huang XN, Sun AS, Shi JS. Protective effects of Ginkgobiloba leaf extract on aluminium-induced brain dysfunction in rats.Life Sci. 2005 ; 27: 140-148.
22. Ravi SM, Parabhu BM, Raju TR, Bindu PN. Long-term effects of postnatal aluminium exposure on acetylcholinestrase activity and biogenic amine neurotransmitters in rat brain. Indian J Physiol Pharmacol. 2000 ; 44 :473-478.
23. Elbina Y, Okada S, Hamazaki S, Midorikawa O. Liver, kiney and central nervous system toxicity of aluminium given intraperitonially to rats : a multiple-dose subchronic study using aluminium chloride. Toxicol Appl Pharmacol. 1984 ; 15: 211-218.
24. Fu HJ, Hu QS, Lin ZN, Ren TL, Song H, Cai CK, Dong SZ. Aluminium-induced apoptosis in cultured cortical neurons and its effect on Sapk/Jink signal transduction pathway. Brain Res. 2003 ; 980. 11-23.
25. Winship KA. Toxicity of aluminium : a histological review 1. Advers Drug React Toxicol Reev. 1992 ; 11: 123-141.
26. Timbrell J.Toxic responses to foreign compounds : Principles of biochemical toxicology. 3rd ed. Taylor and Francis, UK. 2002 : 175-258.
27. Ochmanski W, Barabasz W. Aluminium occurance and toxicity for organisms.Przegl Leuk. 2000 ; 57: 665-668.
28. Yang J, Jia Y, Zhao R, Jin N, Chen J.Effect of exposure to aluminium on some metal elements contents in hippocampus of rat.Zhonghua Yu Fang Yi Xue Za Zhi. 2002 ; 36: 247-249.
29. Gonchev T, Dyankov E, Zacharieva R, Pachalieva I, Velikova M, Kavaldjieva B. Influence of aluminium on erythropoisis, iron metabolism and some functional characteristics of erythrocytes in rats.Acta Physiol Blug. 1998 ; 23:27-31.
30. Fyiad AA. Aluminium toxicity and oxidative damage reduction by melatonin in rats. Journal of Applied Science Research. 2007; 3 : 1210-1217.
31. Nikolova P, Softova E, Kavaldzhieva B, Boiadzhieva S. The functional and morphological changes in the liver and kidneys of white rats with aluminium. EKSP Med Morfol. 1994; 32: 52- 61.
32. Mahieu ST, Gionotti M, Millen N, Elias MM. Effect of chronic accumulation of aluminiumon renal function, cortical renal oxidative stress and cortical renal organic anion transport in rats. Arch Toxicol. 2003 ; 77: 605-612.
